Trial intelligence / Profile preview

SMA CARNI-VAL Trial

NCT00227266Phase 2Completed

Sponsor
University of Utah
Start
Sep 2005
Primary completion
Nov 2007
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of valproic acid in spinal muscular atrophy (SMA), sponsored by University of Utah. Started Sep 2005; status: completed.

02

Drugs

valproic acid
03

Conditions

spinal muscular atrophy (SMA)

Beyond the preview

Go deeper on NCT00227266.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00227266.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call